Expression of E-cadherin in primary and metastatic prostate cancer

Liang Cheng, Moolky Nagabhushan, Theresa P. Pretlow, Saeid B. Amini, Thomas G. Pretlow

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

Immunohistochemical studies have suggested that E-cadherin may be a useful prognostic marker in prostate cancer. Previous studies have depended on cryostat sections of tissues selected grossly. Many prostate cancers, even when extensive, are not visible grossly; many others cannot be demarcated sharply grossly. The wide applicability of prognostic markers after total prostatectomy will depend upon methods that can be applied to tissue selected based upon the histopathological examination of the entire prostate. Our purpose was to investigate the possibility that E-cadherin could be demonstrated in paraffin-embedded whole prostates and metastatic prostate cancer. Microwaving in citrate buffer was the best of five methods tested for the demonstration of E-cadherin in paraffin-embedded prostate and was used to investigate 53 primary prostate cancers from 44 patients and lymph node metastases from 14 patients. Metastases of prostate cancer to lymph nodes expressed less (P = 0.008) E-cadherin than primary prostate cancers. The expression of E-cadherin correlated with the histopathological differentiation (Gleason grade) of primary prostate cancers (P = 0.03, P(trend) = 0.003). The use of monoclonal anti-human E-cadherin (HECD-1) with microwaving in citrate buffer followed by immunoperoxidase staining with heavy metal enhancement for the demonstration of E-cadherin in paraffin- embedded tissue will, for the first time, allow the use of archival tissue for prognostic studies of E-cadherin in prostate cancer and other tissue. Our results are consistent with the hypothesis that aggressive prostate cancers exhibit decreased expression of E-cadherin and demonstrate the feasibility of long-term prognostic studies of this molecule in the usually multiple prostate cancers found in whole, formalin-fixed, paraffin-embedded resected prostates.

Original languageEnglish (US)
Pages (from-to)1375-1380
Number of pages6
JournalAmerican Journal of Pathology
Volume148
Issue number5
StatePublished - May 1996
Externally publishedYes

Fingerprint

Cadherins
Prostatic Neoplasms
Paraffin
Prostate
Citric Acid
Buffers
Lymph Nodes
Neoplasm Metastasis
Prostatectomy
Heavy Metals
Formaldehyde
Staining and Labeling

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Cheng, L., Nagabhushan, M., Pretlow, T. P., Amini, S. B., & Pretlow, T. G. (1996). Expression of E-cadherin in primary and metastatic prostate cancer. American Journal of Pathology, 148(5), 1375-1380.

Expression of E-cadherin in primary and metastatic prostate cancer. / Cheng, Liang; Nagabhushan, Moolky; Pretlow, Theresa P.; Amini, Saeid B.; Pretlow, Thomas G.

In: American Journal of Pathology, Vol. 148, No. 5, 05.1996, p. 1375-1380.

Research output: Contribution to journalArticle

Cheng, L, Nagabhushan, M, Pretlow, TP, Amini, SB & Pretlow, TG 1996, 'Expression of E-cadherin in primary and metastatic prostate cancer', American Journal of Pathology, vol. 148, no. 5, pp. 1375-1380.
Cheng L, Nagabhushan M, Pretlow TP, Amini SB, Pretlow TG. Expression of E-cadherin in primary and metastatic prostate cancer. American Journal of Pathology. 1996 May;148(5):1375-1380.
Cheng, Liang ; Nagabhushan, Moolky ; Pretlow, Theresa P. ; Amini, Saeid B. ; Pretlow, Thomas G. / Expression of E-cadherin in primary and metastatic prostate cancer. In: American Journal of Pathology. 1996 ; Vol. 148, No. 5. pp. 1375-1380.
@article{c8d3e8307e924d6cb272998e670321f5,
title = "Expression of E-cadherin in primary and metastatic prostate cancer",
abstract = "Immunohistochemical studies have suggested that E-cadherin may be a useful prognostic marker in prostate cancer. Previous studies have depended on cryostat sections of tissues selected grossly. Many prostate cancers, even when extensive, are not visible grossly; many others cannot be demarcated sharply grossly. The wide applicability of prognostic markers after total prostatectomy will depend upon methods that can be applied to tissue selected based upon the histopathological examination of the entire prostate. Our purpose was to investigate the possibility that E-cadherin could be demonstrated in paraffin-embedded whole prostates and metastatic prostate cancer. Microwaving in citrate buffer was the best of five methods tested for the demonstration of E-cadherin in paraffin-embedded prostate and was used to investigate 53 primary prostate cancers from 44 patients and lymph node metastases from 14 patients. Metastases of prostate cancer to lymph nodes expressed less (P = 0.008) E-cadherin than primary prostate cancers. The expression of E-cadherin correlated with the histopathological differentiation (Gleason grade) of primary prostate cancers (P = 0.03, P(trend) = 0.003). The use of monoclonal anti-human E-cadherin (HECD-1) with microwaving in citrate buffer followed by immunoperoxidase staining with heavy metal enhancement for the demonstration of E-cadherin in paraffin- embedded tissue will, for the first time, allow the use of archival tissue for prognostic studies of E-cadherin in prostate cancer and other tissue. Our results are consistent with the hypothesis that aggressive prostate cancers exhibit decreased expression of E-cadherin and demonstrate the feasibility of long-term prognostic studies of this molecule in the usually multiple prostate cancers found in whole, formalin-fixed, paraffin-embedded resected prostates.",
author = "Liang Cheng and Moolky Nagabhushan and Pretlow, {Theresa P.} and Amini, {Saeid B.} and Pretlow, {Thomas G.}",
year = "1996",
month = "5",
language = "English (US)",
volume = "148",
pages = "1375--1380",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Expression of E-cadherin in primary and metastatic prostate cancer

AU - Cheng, Liang

AU - Nagabhushan, Moolky

AU - Pretlow, Theresa P.

AU - Amini, Saeid B.

AU - Pretlow, Thomas G.

PY - 1996/5

Y1 - 1996/5

N2 - Immunohistochemical studies have suggested that E-cadherin may be a useful prognostic marker in prostate cancer. Previous studies have depended on cryostat sections of tissues selected grossly. Many prostate cancers, even when extensive, are not visible grossly; many others cannot be demarcated sharply grossly. The wide applicability of prognostic markers after total prostatectomy will depend upon methods that can be applied to tissue selected based upon the histopathological examination of the entire prostate. Our purpose was to investigate the possibility that E-cadherin could be demonstrated in paraffin-embedded whole prostates and metastatic prostate cancer. Microwaving in citrate buffer was the best of five methods tested for the demonstration of E-cadherin in paraffin-embedded prostate and was used to investigate 53 primary prostate cancers from 44 patients and lymph node metastases from 14 patients. Metastases of prostate cancer to lymph nodes expressed less (P = 0.008) E-cadherin than primary prostate cancers. The expression of E-cadherin correlated with the histopathological differentiation (Gleason grade) of primary prostate cancers (P = 0.03, P(trend) = 0.003). The use of monoclonal anti-human E-cadherin (HECD-1) with microwaving in citrate buffer followed by immunoperoxidase staining with heavy metal enhancement for the demonstration of E-cadherin in paraffin- embedded tissue will, for the first time, allow the use of archival tissue for prognostic studies of E-cadherin in prostate cancer and other tissue. Our results are consistent with the hypothesis that aggressive prostate cancers exhibit decreased expression of E-cadherin and demonstrate the feasibility of long-term prognostic studies of this molecule in the usually multiple prostate cancers found in whole, formalin-fixed, paraffin-embedded resected prostates.

AB - Immunohistochemical studies have suggested that E-cadherin may be a useful prognostic marker in prostate cancer. Previous studies have depended on cryostat sections of tissues selected grossly. Many prostate cancers, even when extensive, are not visible grossly; many others cannot be demarcated sharply grossly. The wide applicability of prognostic markers after total prostatectomy will depend upon methods that can be applied to tissue selected based upon the histopathological examination of the entire prostate. Our purpose was to investigate the possibility that E-cadherin could be demonstrated in paraffin-embedded whole prostates and metastatic prostate cancer. Microwaving in citrate buffer was the best of five methods tested for the demonstration of E-cadherin in paraffin-embedded prostate and was used to investigate 53 primary prostate cancers from 44 patients and lymph node metastases from 14 patients. Metastases of prostate cancer to lymph nodes expressed less (P = 0.008) E-cadherin than primary prostate cancers. The expression of E-cadherin correlated with the histopathological differentiation (Gleason grade) of primary prostate cancers (P = 0.03, P(trend) = 0.003). The use of monoclonal anti-human E-cadherin (HECD-1) with microwaving in citrate buffer followed by immunoperoxidase staining with heavy metal enhancement for the demonstration of E-cadherin in paraffin- embedded tissue will, for the first time, allow the use of archival tissue for prognostic studies of E-cadherin in prostate cancer and other tissue. Our results are consistent with the hypothesis that aggressive prostate cancers exhibit decreased expression of E-cadherin and demonstrate the feasibility of long-term prognostic studies of this molecule in the usually multiple prostate cancers found in whole, formalin-fixed, paraffin-embedded resected prostates.

UR - http://www.scopus.com/inward/record.url?scp=0029865275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029865275&partnerID=8YFLogxK

M3 - Article

VL - 148

SP - 1375

EP - 1380

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -